Biogen has reached a deal to buy Alcyone Therapeutics, a privately held company that has developed a system for delivering ...

UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of ...

The UK's Royal College of Psychiatrists (RCPsych) has published a report that calls for more clinical testing of psychedelic ...

Panellists voted by 8 to 3 – with one abstention – to change the CDC recommendations to state that MMRV is not recommended ...

Newly launched ophthalmology company Ollin Biosciences has emerged onto the scene with $100 million in backing and a mission to bring a rival drug for wet age-related macular degeneration (AMD) that ...

In today's pharmaphorum podcast, host Jonah Comstock speaks with Alice Valder Curran, a partner at Hogan Lovells and our ...

Alzheimer’s and Parkinson’s pipelines are rapidly expanding beyond amyloid and into next-generation mechanisms such as ...

Dr Susan Monarez told lawmakers today that Health and Human Services (HHS) Secretary Robert F Kennedy Jr said he planned to ...

There is only one approved drug for ultra-rare disease fibrodysplasia ossificans progressiva (FOP) on the US market, but ...

The $14.50-per-share deal equates to a purchase price of $2.4 billion at closing, with Roche dangling another $6 per share in ...

UK-based electronRx will launch a digital health technology (DHT) to help patients with respiratory disease manage their ...

With the much-anticipated release today of the Make America Healthy Again report and strategy document, the US Department of ...